YF476 and Type II Gastric Carcinoids

Clinical trial NCT02454075 · TERMINATED

Trial details

NCT number: NCT02454075
Sponsor: Trio Medicines Ltd.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Zollinger-Ellison Syndrome

Start date: 2011-04-11
Primary completion: 2012-06-22
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.